doi: 10.1016/j.bone.2024.117338
Together, they could theoretically create a vehicle that not only runs optimally but also performs with superior metabolic efficiency
declares funding to conduct clinical trials from AstraZeneca, Bayer, Boehringer Ingelheim and Novo Nordisk (all to the FIDES Research Foundation) and payment of honoraria for lectures from AstraZeneca, Novo Nordisk, Baxter, Chiesi, ChemoCentrix, Clarion and Boehringer Ingelheim
GLP-1s appear to have a strong effect in reducing suicidal ideation and suicide attempts, as discussed below, both of which are common among SUD patients
Semaglutide is generally considered more effective for long-term weight loss due to its ability to help maintain weight loss over time, while Phentermine is typically used for short-term weight reduction